SG Americas Securities
FULC icon

SG Americas Securities’s Fulcrum Therapeutics FULC Stock Holding History

SG Americas Securities’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93K Buy
12,139
+373
+3% +$3.46K ﹤0.01% 2947
2025
Q4 		$133K Buy
+11,766
New +$120K ﹤0.01% 3105
2025
Q2 		– Sell
-25,375
Closed -$73K – 3177
2025
Q1 		$73K Sell
25,375
-5,067
-17% -$18.6K ﹤0.01% 3144
2024
Q4 		$143K Sell
30,442
-2,577
-8% -$9.51K ﹤0.01% 2449
2024
Q3 		$118K Buy
33,019
+6,926
+27% +$51.4K ﹤0.01% 2934
2024
Q2 		$162K Buy
26,093
+13,887
+114% +$105K ﹤0.01% 2278
2024
Q1 		$115K Buy
+12,206
New +$109K ﹤0.01% 2445
2023
Q2 		– Sell
-24,951
Closed -$71K – 2597
2023
Q1 		$71K Buy
24,951
+8,918
+56% +$79.9K ﹤0.01% 3004
2022
Q4 		$117K Buy
16,033
+4,198
+35% +$27.4K ﹤0.01% 2612
2022
Q3 		$96K Sell
11,835
-1,338
-10% -$9.58K ﹤0.01% 2867
2022
Q2 		$65K Buy
13,173
+8,884
+207% +$86.8K ﹤0.01% 3227
2022
Q1 		$101K Sell
4,289
-7,563
-64% -$107K ﹤0.01% 2768
2021
Q4 		$210K Sell
11,852
-7,376
-38% -$146K ﹤0.01% 2650
2021
Q3 		$542K Buy
+19,228
New +$364K ﹤0.01% 2420
2020
Q3 		– Sell
-6,862
Closed -$126K – 2966
2020
Q2 		$126K Buy
+6,862
New +$108K ﹤0.01% 3212

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

SG Americas Securities's FULC Position: Q1 2026 in Review

SG Americas Securities increased its Fulcrum Therapeutics (FULC) stake by 3.2% in Q1 2026, buying an estimated $3.46K and bringing the position to 12,139 shares worth $93K. The position accounts for ﹤0.01% of the portfolio, ranked #2947.

SG Americas Securities first reported a position in FULC in Q2 2020 and has held it in 15 quarters since. The position peaked at $542K in Q3 2021. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • SG Americas Securities held 12,139 shares of Fulcrum Therapeutics worth $93K as of Q1 2026.
  • SG Americas Securities bought 373 Fulcrum Therapeutics shares in Q1 2026, an estimated $3.46K.
  • Fulcrum Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2947 holding.
  • SG Americas Securities first reported a position in Fulcrum Therapeutics in Q2 2020 and has held it in 15 quarters since.
  • SG Americas Securities's Fulcrum Therapeutics position peaked at $542K in Q3 2021.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.